Association between serum uric acid level and hypertension in a Chinese elderly rural population

References

• Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365:217–23.
   PubMed Web of Science ®Google Scholar
• Wolf-Maier K, Cooper RS, Banegas JR, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. Jama 2003;289:2363–69.
   PubMed Web of Science ®Google Scholar
• Ong KL, Cheung BM, Man YB, et al. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 2007;49:69–75.
   PubMed Web of Science ®Google Scholar
• Gu D, Reynolds K, Wu X, et al. InterASIA Collaborative Group. The International Collaborative Study of Cardiovascular Disease in ASIA. Prevalence, awareness, treatment, and control of hypertension in china. Hypertension 2002;40:920–27.
   Google Scholar
• Wang ZH, Wang LH, Li YC, et al. Current status of diabetes, hypertension and dyslipidemia among older Chinese adults in 2010. Chin J Prev Med 2012;46:922–26. article in Chinese
   Google Scholar
• Bromfield SG, Bowling CB, Tanner RM, et al. Trends in hypertension prevalence, awareness, treatment, and control among US adults 80 years and older, 1988-2010. J Clin Hypertens (Greenwich) 2014;16:270–76.
   PubMed Web of Science ®Google Scholar
• Lewington S, Clarke R, Qizilbash N, et al. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903–13.
   PubMed Web of Science ®Google Scholar
• Wang S, Shu Z, Tao Q, et al. Uric acid and incident chronic kidney disease in a large health check-up population in Taiwan. Nephrology 2011;16:767–76.
   PubMed Web of Science ®Google Scholar
• Nagahama K, Inoue T, Kohagura K, et al. Hyperuricemia predicts future metabolic syndrome: a 4-year follow-up study of a large screened cohort in Okinawa, Japan. Hypertens Res 2014;37:232–38.
   PubMed Web of Science ®Google Scholar
• Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. New Engl J Med 2008;359:1811–21.
   PubMed Web of Science ®Google Scholar
• Yoshitomi R, Fukui A, Nakayama M, et al. Sex differences in the association between serum uric acid levels and cardiac hypertrophy in patients with chronic kidney disease. Hypertens Res 2014;37:246–52.
   PubMed Web of Science ®Google Scholar
• Kawai T, Ohishi M, Takeya Y, et al. Serum uric acid is an independent risk factor for cardiovascular disease and mortality in hypertensive patients. Hypertens Res 2012;35:1087–92.
   PubMed Web of Science ®Google Scholar
• Ito S, Naritomi H, Ogihara T, et al. Impact of serum uric acid on renal function and cardiovascular events in hypertensive patients treated with losartan. Hypertens Res 2012;35:867–7.
   PubMed Web of Science ®Google Scholar
• Grayson PC, Kim SY, LaValley M, Choi HK. Hyperuricemia and Incident Hypertension: A Systematic Review and Meta-Analysis. Arthritis Care Res (Hoboken) 2011;63:102–10.
   PubMed Web of Science ®Google Scholar
• Wang J, Qin T, Chen J, et al. Hyperuricemia and risk of incident hypertension: a systematic review and meta-analysis of observational studies. PLoS One 2014;9:e114259.
   PubMed Web of Science ®Google Scholar
• Yokokawa H, Fukuda H, Suzuki A, et al. Association between serum uric acid levels/hyperuricemia and hypertension among 85,286 Japanese workers. J Clin Hypertens (Greenwich) 2016;18:53–59.
   PubMed Web of Science ®Google Scholar
• Kansui Y, Ohtsubo T, Goto K, et al. Association of serum uric acid with blood pressure in Japanese men. Cross-sectional study in work-site group. Circ J 2011;75:2827–32.
   Google Scholar
• Shankar A, Klein R, Klein BE, Nieto FJ. The association between serum uric acid level and long-term incidence of hypertension: population-based cohort study. J Hum Hypertens 2006;20:937–45.
   PubMed Web of Science ®Google Scholar
• Feig DI, Soletsky B, Johnson RJ. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. Jama 2008;300:924–32.
   PubMed Web of Science ®Google Scholar
• Soletsky B, Feig DI. Uric acid reduction rectifies prehypertension in obese adolescents. Hypertension 2012;60:1148–56.
   PubMed Web of Science ®Google Scholar
• Liu R, Han C, Wu D, et al. Prevalence of hyperuricemia and gout in Mainland China from 2000 to 2014: a systematic review and meta-analysis. Biomed Res Int 2015;2015:762820.
   PubMed Web of Science ®Google Scholar
• Wu L, He Y, Jiang B, et al. Trends in prevalence, awareness, treatment and control of hypertension during 2001-2010 in an urban elderly population of China. PLOS One 2015;10:e0132814.
   PubMed Web of Science ®Google Scholar
• Population division of the department of economic and social affairs of the United Nations secretariat, World Population Prospects. The 2010 revision (on-line). Available at http://esa.un.org/unpd/wpp/unpp/panel_population.htm Accessed March 10, 2013.
   Google Scholar
• Smith JP, Strauss J, Zhao Y. Healthy aging in China. J Econ Ageing 2014;4:37–43.
   PubMedGoogle Scholar
• People’ s Republic of China Ministry of Health Disease Control Division. Overweight and obesity prevention and control guidelines in Chinese adults (R).Beijing: People’s Medical Publishing House. 2003.
   Google Scholar
• Yang GH, Li Q, Wang CX, et al. Findings from 2010 Global Adult Tobacco Survey: implementation of MPOWER policy in China. Biomed Environ Sci 2010;23:422–29.
   PubMed Web of Science ®Google Scholar
• Xu Y, Wang L, He J, et al. 2010 China Noncommunicable Disease Surveillance Group. Prevalence and control of diabetes in Chinese adults. Jama 2013;310:948–59.
   Google Scholar
• Liu M, He Y, Jiang B, et al. Association between serum uric acid level and metabolic syndrome and its sex difference in a Chinese community elderly population. Int J Endocrinol 2014;11: 2014:754678.
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, et al. Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003;42:1206–52.
   Google Scholar
• Kuwabara M, Niwa K, Nishi Y, et al. Relationship between serum uric acid levels and hypertension among Japanese individuals not treated for hyperuricemia and hypertension. Hypertens Res 2014;37:785–89.
   PubMed Web of Science ®Google Scholar
• Syamala S, Li J, Shankar A. Association between serum uric acid and prehypertension among US adults. J Hypertens 2007;25:1583–89.
   PubMed Web of Science ®Google Scholar
• Sundström J, Sullivan L, D’Agostino RB, et al. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension 2005;45:28–33.
   PubMed Web of Science ®Google Scholar
• Fang J, Alderman MH. Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow-up study, 1971–1992. National Health and Nutrition Examination Survey. Jama 2000;283:2404–10.
   Google Scholar
• Matsumura K, Ohtsubo T, Oniki H, et al. Gender-related association of serum uric acid and left ventricular hypertrophy in hypertension. Circ J 2006;70:885–88.
   PubMed Web of Science ®Google Scholar
• Gaffo AL, Jacobs DR Jr, Sijtsma F, et al. Serum urate association with hypertension in young adults: analysis from the Coronary Artery Risk Development in Young Adults cohort. Ann Rheum Dis 2013;72:1321–27.
   PubMed Web of Science ®Google Scholar
• Loeffler LF, Navas-Acien A, Brady TM, et al. Uric acid level and elevated blood pressure in US adolescents: National Health and Nutrition Examination Survey, 1999-2006. Hypertension 2012;59:811–17.
   PubMed Web of Science ®Google Scholar
• Muscelli E, Natali A, Bianchi S, et al. Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am J Hypertens 1996;9:746–52.
   PubMed Web of Science ®Google Scholar
• Yoo TW, Sung KC, Shin HS, et al. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J 2005;69:928–33.
   PubMed Web of Science ®Google Scholar
• Rao GN, Corson MA, Berk BC. Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression. J Biol Chem 1991;266:8604–08.
   PubMed Web of Science ®Google Scholar
• Mazzali M, Kanellis J, Han L, et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Ren Physiol 2002;282:F991–F997.
   PubMed Web of Science ®Google Scholar
• Butler R, Morris AD, Belch JJ, et al. Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 2000;35:746–51.
   PubMed Web of Science ®Google Scholar
• Kang DH, Park SK, Lee IK, Johnson RJ. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 2005;16:3553–62.
   PubMed Web of Science ®Google Scholar
• Doehner W, Schoene N, Rauchhaus M, et al. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies. Circulation 2002;105:2619–24.
   PubMed Web of Science ®Google Scholar
• Perlstein TS, Gumieniak O, Hopkins PN, et al. Uric acid and the state of the intrarenal renin–angiotensin system in humans. Kidney Int 2004;66:1465–70.
   PubMed Web of Science ®Google Scholar
• Mene P, Punzo G. Uric acid: bystander or culprit in hypertension and progressive renal disease?. J Hypertens 2008;26:2085–92.
   PubMed Web of Science ®Google Scholar
• Mazzali M, Hughes J, Kim YG, et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 2001;38:1101–06.
   PubMed Web of Science ®Google Scholar
• Dahle DO, Jenssen T, Holdaas H, et al. Uric acid has a J-shaped association with cardiovascular and all-cause mortality in kidney transplant recipients. Clin Transplant 2014;28:134–40.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Schillaci G, Reboldi G, et al. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA Study. Hypertension 2000;36:1072–78.
   PubMed Web of Science ®Google Scholar
• Liu Q, Han L, Du Q, et al. The association between oxidative stress, activator protein-1, inflammatory, total antioxidant status and artery stiffness and the efficacy of olmesartan in elderly patients with mild-to-moderate essential hypertension. Clin Exp Hypertens 2016;38:365–69.
   PubMed Web of Science ®Google Scholar
• De Champlain J, Wu R, Girouard H, et al. Oxidative stress in hypertension. Clin Exp Hypertens 2004;26:593–601.
   PubMed Web of Science ®Google Scholar